You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anaplastic Astrocytoma

Showing 1 - 25 of 680
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

Active, not recruiting
  • Astrocytoma
  • Glioblastoma
  • Jacksonville, Florida
  • +8 more
Dec 14, 2022

IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

Terminated
Has Results
  • IDH Family Wildtype
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    Has Results
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

    Not yet recruiting
    • Glioblastoma Multiforme
    • +4 more
    • SIACI of cetuximab and bevacizumab
    • Miami, Florida
      Jackson Memorial Hospital
    Jul 14, 2023

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)

    Suspended
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • Bevacizumab and Carboplatin
    • New York, New York
      Lenox Hill Brain Tumor Center
    Oct 27, 2021

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

    Active, not recruiting
    • Glioblastoma Multiforme of Brain
    • +2 more
    • C134
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 19, 2022

    Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

    Active, not recruiting
    • Recurrent Glioblastoma Multiforme
    • +2 more
    • M032 (NSC 733972)
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 26, 2022

    Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

    Active, not recruiting
    • Glioma, Malignant
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2022

    Loupe-Based Intraoperative Fluorescence Imaging

    Recruiting
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
      • Lexington, Kentucky
        University of Kentucky
      Mar 3, 2022

      Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

      Withdrawn
      • Recurrent Anaplastic Astrocytoma
      • +7 more
      • Neural Stem Cells-expressing CRAd-S-pk7
      • Resection
      • (no location specified)
      Nov 22, 2022

      Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

      Completed
      • Malignant Glioma
      • +3 more
      • Dendritic Cell Vaccine
      • +3 more
      • Miami, Florida
        University of Miami
      Jul 19, 2022

      Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

      Active, not recruiting
      • Brain Tumor, Recurrent
      • +4 more
      • Cytoreductive surgery
      • +2 more
      • New York, New York
      • +1 more
      Jun 9, 2022

      Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

      Recruiting
      • Recurrent High-grade Glioma
      • +3 more
      • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
      • +2 more
      • Incheon, Korea, Republic of
        Gachon University Gil Medical Center
      Feb 19, 2023

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

      Terminated
      Has Results
      • Glioblastoma Multiforme
      • +3 more
      • Indianapolis, Indiana
        Riley Hospital for Children at IU Health
      Jul 21, 2022

      Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

      Not yet recruiting
      • Neoplasms
      • +7 more
      • Biological G207
      • Birmingham, Alabama
        Children's of Alabama
      Jun 1, 2022

      Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

      Active, not recruiting
      • Astrocytoma, IDH-Mutant, Grade 2
      • Astrocytoma, IDH-Mutant, Grade 3
      • Questionnaire Administration
      • +3 more
      • Phoenix, Arizona
      • +24 more
      Dec 7, 2022

      Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))

      Completed
      Has Results
      • Brain Tumor
      • +4 more
      • Zotiraciclib (TG02)
      • Temozolomide (TMZ)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 3, 2021

      CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

      Recruiting
      • Central Nervous System Neoplasms
      • +22 more
      • Bethesda, Maryland
        National Institutes of Health
      Mar 1, 2022